Kelly E. McCann, MD, PhD, is an assistant professor and breast medical oncologist at UCLA.

Sara A. Hurvitz, MD, FACP, is a medical oncologist, senior vice president, professor in, and director of the Clinical Research Division at Fred Hutchinson Cancer Center in Seattle, Washington. She also serves as the Smith Family Endowed Chair in Women’s Health.

Advancements in Adjuvant Therapy in Early-Stage HR+ Breast Cancer

Video content above is prompted by the following:

How does biomarker testing differ in advanced/metastatic breast cancer from early-stage disease?

Videos

A panel of experts discuss advancements in adjuvant therapy for early-stage breast cancer.

Insights from TAILORx and RxPONDER in Guiding Treatment in Early-Stage HR+ Breast Cancer

What other strategies show promise for early-stage HR+ breast cancer?

Expert breast oncologists examine adjuvant therapy approaches for early-stage hormone receptor-positive breast cancer, emphasizing the distinct treatment strategies and outcomes observed in pre- and post-menopausal patient populations.

Expert Insights on Biomarker Testing in Early-Stage Breast Cancer

What do you consider best practices for biomarker testing in early-stage breast cancer?

Identify key treatment approaches for patients with early-stage HR+ breast cancer.

Leading oncologists explore optimal biomarker testing strategies for early-stage breast cancer, examining the comparative advantages of tissue and liquid biopsies to guide personalized treatment decisions.

Hope S. Rugo, MD, is the Director of the Women's Cancers Program, the Division Chief of Breast Medical Oncology, and a Professor in the Department of Medical Oncology & Therapeutics Research at City of Hope Comprehensive Cancer Center. She is also a Professor Emeritus at UCSF

, which provides oncology professionals with the resources and information they need to provide the best patient care. In both digital and print formats, 

 covers every angle of oncology practice, from new technology to treatment advances to important regulatory decisions.

In today’s episode, supported by Pfizer and Novartis, we had the pleasure of speaking with the panelists from 

 inaugural Women in Oncology event, which took place during the 

, is the director of Breast Oncology at Lifespan Cancer Institute, as well as an associate professor of medicine at Brown University, both in Providence, Rhode Island. 

, is a medical oncologist at Miami Cancer Institute and chief of Breast Medical Oncology at Baptist Health’s Wellness and Medical Complex in Florida. 

, is a breast medical oncologist and an assistant clinical professor of medicine at the University of California, Los Angeles Health David Geffen School of Medicine. 

, is the Winterhof Family Endowed Professor in Breast Cancer at the University of California San Francisco (UCSF), as well as a professor of medicine in the Division of Hematology and Oncology, director of Breast Oncology, director of Clinical Trials Education, and director of Cancer Infusion Services at the UCSF Helen Diller Family Comprehensive Cancer Center. 

In our exclusive interview, Drs Graff, Mahtani, McCann, and Rugo shared moments throughout their lives and careers that sparked their interest in oncology, setbacks they overcame when building their careers, obstacles they continue to encounter as women in the field, and ways that gender bias can be confronted at both the individual and institutional levels.

That’s all we have for today! Thank you for listening to this episode of 

, supported by Pfizer and Novartis. Check back on Mondays and Thursdays for exclusive interviews with leading experts in the oncology field.

For more updates in oncology, be sure to visit www.OncLive.com and sign up for our e-newsletters.

 is also on social media. On Twitter, follow us at @OncLive. On Facebook, like us at OncLive, and follow our OncLive page on LinkedIn.

, please consider subscribing to our podcast on Apple Podcasts, Spotify, Google Podcasts, Amazon Music, and many of your other favorite podcast platforms,* so you get a notification every time a new episode is posted. While you are there, please take a moment to rate us!

*OncLive On Air is available on: Apple Podcasts, Google Podcasts, Spotify, Amazon Music, Audacy, CastBox, Deezer, iHeart, JioSaavn, Listen Notes, Player FM, Podcast Addict, Podchaser, RadioPublic, and TuneIn.

Podcasts

Drs Graff, Mahtani, McCann, and Rugo share moments that sparked their interest in oncology and setbacks they overcame when building their careers. 


Kelly E. McCann, MD, PhD

Articles

Advancements in Adjuvant Therapy in Early-Stage HR+ Breast Cancer

Insights from TAILORx and RxPONDER in Guiding Treatment in Early-Stage HR+ Breast Cancer

Expert Insights on Biomarker Testing in Early-Stage Breast Cancer

Breast Cancer Experts Share Obstacles and Successes as Women in Oncology